scispace - formally typeset
A

Anna Casasent

Researcher at University of Texas MD Anderson Cancer Center

Publications -  14
Citations -  1087

Anna Casasent is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Biology & Breast cancer. The author has an hindex of 5, co-authored 7 publications receiving 739 citations.

Papers
More filters
Journal ArticleDOI

Punctuated copy number evolution and clonal stasis in triple-negative breast cancer

TL;DR: A highly multiplexed single-nucleus sequencing method is developed to investigate copy number evolution in patients with triple-negative breast cancer, showing that the majority of copy number aberrations are acquired at the earliest stages of tumor evolution, in short punctuated bursts that form the tumor mass.
Journal ArticleDOI

Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing

TL;DR: Topographic Single Cell Sequencing data reveal a direct genomic lineage between in situ and invasive tumor subpopulations and further show that most mutations and copy number aberrations evolved within the ducts prior to invasion.
Journal ArticleDOI

Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer.

TL;DR: A highly multiplexed single-cell DNA sequencing approach was developed to trace the metastatic lineages of two CRC patients with matched liver metastases and revealed an unexpected independent tumor lineage that did not metastasize, and early progenitor clones with the "first hit" mutation in APC that subsequently gave rise to both the primary and metastatic tumors.
Journal ArticleDOI

Breast tumours maintain a reservoir of subclonal diversity during expansion

TL;DR: In this article, a single-cell, single-molecule DNA-sequencing method was used to investigate copy number evolution during the expansion of primary breast tumours and showed that triple-negative breast cancers continue to evolve chromosome aberrations and maintain a reservoir of subclonal diversity during primary tumour growth.
Journal ArticleDOI

Genome evolution in ductal carcinoma in situ: invasion of the clones

TL;DR: The role of intratumour heterogeneity in the progression of DCIS to IDC is discussed in the context of three evolutionary models: independent lineages, evolutionary bottlenecks, and multiclonal invasion.